Brief: Briacell To Buy Back Up To 10% Of Common Shares, 10% Of Listed Warrants
09/09/2021 15:06
Sept 9 (Reuters) - Briacell Therapeutics Corp BCT.V :
* BRIACELL ANNOUNCES SECURITIES BUYBACK TO PURCHASE UP TO
10% OF
COMMON SHARES AND UP TO 10% OF LISTED WARRANTS
Source text for Eikon: ID:nGNX5BrVRY
Further company coverage: BCT.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study